Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
248
-
Total 13F shares, excl. options
-
114M
-
Shares change
-
+6.6M
-
Total reported value, excl. options
-
$5.61B
-
Value change
-
+$348M
-
Put/Call ratio
-
0.44
-
Number of buys
-
162
-
Number of sells
-
-94
-
Price
-
$49.38
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q2 2017
306 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q2 2017.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 248 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 114M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (11.1M shares), WELLINGTON MANAGEMENT GROUP LLP (8.98M shares), BlackRock Inc. (8.52M shares), JPMORGAN CHASE & CO (6.91M shares), VANGUARD GROUP INC (6.25M shares), Aristotle Capital Management, LLC (4.75M shares), GOLDMAN SACHS GROUP INC (4.38M shares), WELLS FARGO & COMPANY/MN (3.93M shares), BAIN CAPITAL INVESTORS LLC (3.45M shares), and FMR LLC (2.78M shares).
This table shows the top 248 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.